Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |